The 2019 edition of the European Society of Cardiology congress recorded a boom in participants, over 33,000 attendees, many of whom came from other continents (19% from Asia, 16% from the Americas). It was an opportunity to address numerous hot topics, such as the clinical consequences of gender differences, the use of cutting edge therapies, the need for clinic and cardiovascular research to deal with AI and Big Data, as well as the advancement in technologies.
The 2019 edition of the European Society of Cardiology congress recorded a boom in participants, over 33,000 attendees, many of whom came from other continents (19% from Asia, 16% from the Americas). It was an opportunity to address numerous hot topics, such as the clinical consequences of gender differences, the use of cutting edge therapies, the need for clinic and cardiovascular research to deal with AI and Big Data, as well as the advancement in technologies.
hot topic - gender differences in the management of cardiovascular diseases
More women in future studies to investigate gender differences
Women's involvement in decision-making improves outcomes
Do women experience heart failure in a different way?
Male and female physicians: differences in treating patients
Gender differences in the diagnosis and treatment of Isch. H.D.
Women and men: different outcomes from similar treatments
Women's peculiarities may lead to worse outcomes in PCI
M. Infarction: gender differences in pre- and in-hospital delays
interviews
Linee guida ESC sull'ipertensione un anno dopo: quali novità
The role of SGLT2i in cardiovascular risk, kidney disease and HF
Rivascolarizzazione "culprit" o completa nella SCA-STEMI?
Wearables, implantables, AI in the future of AF detection
Managing mitral regurgitation in heart failure
EXPAND Study: next generation MitraClip, performance and safety
Bioprotesi aortiche degenerate: il parametro del "profilo di rischio"
Controversies in the treatment of aortic valve disease
Streamlining rules to revitalize randomized trials
Adaptive Bayesian designs improve trial efficiency
CVD prevention impact in middle income countries
The principles of translational research for CVD devices
Bare metal stents vs drug-eluting stents, a wide meta-analysis
Three important studies on valvular heart disease
